Palliation in patients with malignant gastric outlet obstruction with a newly designed enteral stent: a multicenter study.
BACKGROUND
Through-the-scope (TTS) stents facilitate palliative enteral stent placement. However, most TTS stents are braided, a characteristic that has been associated with significant foreshortening and relatively frequent migration.


OBJECTIVE
To evaluate clinical experience with a new woven enteral stent in the treatment of gastric outlet obstruction.


METHODS
From January 2005 to August 2006, patients with unresectable malignant gastric outlet obstruction were offered stent placement with a new woven stent.


METHODS
Three referral hospitals in Japan.


METHODS
Thirty-seven consecutive patients with malignant gastric outlet obstruction.


METHODS
A newly designed enteral stent was placed by using the TTS placement technique.


METHODS
Palliation efficacy and safety of the new stents.


RESULTS
Stent placement was successful in 36 of 37 patients (technical success, 97%). Thirty-four patients were able to tolerate oral intake without obstructive symptoms (clinical success, 94.4%). Complications occurred in 16.2% of patients, comprising 2 cases of primary stent dysfunction, 1 perforation, 1 GI bleeding, 1 stent obstruction, and 1 biliary stent dysfunction. No migration was seen during the median follow-up period of 68 days.


CONCLUSIONS
Small sample size and relatively brief follow-up.


CONCLUSIONS
A newly developed enteral stent with higher flexibility and less foreshortening offers comparable clinical outcome to existing stents and a lower frequency of complications, including migration.
Maetani
Iruru
I
Division of Gastroenterology, Department of Internal Medicine, Toho University Ohashi Medical Center, Tokyo, Japan.
Isayama
Hiroyuki
H
Mizumoto
Yoshinori
Y
D000368:Aged; D000497:Alloys; D004867:Equipment Design; D005260:Female; D017219:Gastric Outlet Obstruction / Q000209:etiology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000150:complications / Q000401:mortality; D015607:Stents / Q000009:adverse effects; D013274:Stomach Neoplasms / Q000150:complications / Q000401:mortality; D015996:Survival Rate
D000497:Alloys; C013616:nitinol